multiplex protein array plates (Meso Scale Diagnostics LLC)
90
Structured Review
Meso Scale Diagnostics LLC
multiplex protein array plates
Multiplex Protein Array Plates, supplied by Meso Scale Diagnostics LLC, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/multiplex+array+plates/multiplex+protein+array+plates/pmc06320284-265-45-50
Average 90 stars, based on 1 article reviews
Multiplex Protein Array Plates, supplied by Meso Scale Diagnostics LLC, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/multiplex+array+plates/multiplex+protein+array+plates/pmc06320284-265-45-50
Average 90 stars, based on 1 article reviews
multiplex protein array plates - by Bioz Stars,
2026-10
90/100 stars
Images
Related Articles
Clinical Proteomics:Article Title: A Phase II and Biomarker Study of Sorafenib Combined with Modified FOLFOX in Patients with Advanced Hepatocellular Carcinoma (HCC) Article Snippet: .. Plasma analysis was carried out for a panel of circulating pro-angiogenic and pro-inflammatory biomarkers: VEGF, placental growth factor (PlGF), soluble (s)VEGFR1/FLT-1, basic fibroblast growth factor (bFGF), VEGF-C, VEGF-D, sTIE-2, interleukin (IL)-1β, IL-2, IL-4, IL-6, IL-8, IL-10, IL-12p70, interferon (IFN)-α, and tumor necrosis factor (TNF)-α using Article Title: A Phase II and Biomarker Study of Sorafenib Combined with Modified FOLFOX in Patients with Advanced Hepatocellular Carcinoma Article Snippet: .. Plasma analysis was carried out for a panel of circulating pro-angiogenic and proinflammatory biomarkers: VEGF, placental growth factor (PlGF), soluble (s)VEGFR1/FLT-1, basic fibroblast growth factor (bFGF), VEGF-C, VEGF-D, sTIE-2, interleukin (IL)-1, IL-2, IL-4, IL-6, IL-8, IL-10, IL-12p70, interferon (IFN)-α, and tumor necrosis factor (TNF)-α using Article Title: A Phase II and Biomarker Study of Cabozantinib in Patients with Advanced Cholangiocarcinoma Article Snippet: .. Plasma analysis was carried out for a panel of circulating pro-angiogenic and pro-inflammatory biomarkers: VEGF, placental growth factor (PlGF), soluble (s)VEGFR1/FLT-1, basic fibroblast growth factor (bFGF), VEGF-C, VEGF-D, TIE-2, interleukin (IL)-1β, IL-2, IL-4, IL-6, IL-8, IL-10, IL-12p70, interferon (IFN)-γ, and tumor necrosis factor (TNF)-α using Multiplex Assay:Article Title: A Phase II and Biomarker Study of Sorafenib Combined with Modified FOLFOX in Patients with Advanced Hepatocellular Carcinoma (HCC) Article Snippet: .. Plasma analysis was carried out for a panel of circulating pro-angiogenic and pro-inflammatory biomarkers: VEGF, placental growth factor (PlGF), soluble (s)VEGFR1/FLT-1, basic fibroblast growth factor (bFGF), VEGF-C, VEGF-D, sTIE-2, interleukin (IL)-1β, IL-2, IL-4, IL-6, IL-8, IL-10, IL-12p70, interferon (IFN)-α, and tumor necrosis factor (TNF)-α using Article Title: Systemic inflammation following traumatic injury and its impact on neuroinflammatory gene expression in the rodent brain Article Snippet: .. Serum interleukin-beta (IL-β), interleukin-6 (IL-6), chemokine (C-X-C motif) ligand 1 (CXCL1), tumor necrosis factor alpha (TNF-α), monocyte chemoattractant protein-1 (MCP-1; CCL2) and interferon gamma (IFN-γ) levels were assayed at 1, 3, 6, 24, 72, and 168 hpi using Article Title: Cutaneous burn injury represents a major risk factor for the development of traumatic ectopic bone formation following blast-related extremity injury. Article Snippet: Blast-related traumatic heterotopic ossification (tHO) impacts clinical outcomes in combat-injured patients, leading to delayed wound healing, inflammatory complications, and reduced quality of life.. Blast injured patients often have significant burns.. This study investigated whether a partial thickness thermal burn injury exacerbates blast-related tHO in a clinically relevant polytrauma animal model. Article Title: A Phase II and Biomarker Study of Sorafenib Combined with Modified FOLFOX in Patients with Advanced Hepatocellular Carcinoma Article Snippet: .. Plasma analysis was carried out for a panel of circulating pro-angiogenic and proinflammatory biomarkers: VEGF, placental growth factor (PlGF), soluble (s)VEGFR1/FLT-1, basic fibroblast growth factor (bFGF), VEGF-C, VEGF-D, sTIE-2, interleukin (IL)-1, IL-2, IL-4, IL-6, IL-8, IL-10, IL-12p70, interferon (IFN)-α, and tumor necrosis factor (TNF)-α using Article Title: Systemic inflammation following traumatic injury and its impact on neuroinflammatory gene expression in the rodent brain. Article Snippet: .. Serum interleukin-beta (IL-β), interleukin-6 (IL-6), chemokine (C-X-C motif ) ligand 1 (CXCL1), tumor necrosis factor alpha (TNF-α), monocyte chemoattractant protein-1 (MCP-1; CCL2) and interferon gamma (IFN-γ) levels were assayed at 1, 3, 6, 24, 72, and 168 hpi using Article Title: A Phase II and Biomarker Study of Cabozantinib in Patients with Advanced Cholangiocarcinoma Article Snippet: .. Plasma analysis was carried out for a panel of circulating pro-angiogenic and pro-inflammatory biomarkers: VEGF, placental growth factor (PlGF), soluble (s)VEGFR1/FLT-1, basic fibroblast growth factor (bFGF), VEGF-C, VEGF-D, TIE-2, interleukin (IL)-1β, IL-2, IL-4, IL-6, IL-8, IL-10, IL-12p70, interferon (IFN)-γ, and tumor necrosis factor (TNF)-α using Protein Array:Article Title: A Phase II and Biomarker Study of Sorafenib Combined with Modified FOLFOX in Patients with Advanced Hepatocellular Carcinoma (HCC) Article Snippet: .. Plasma analysis was carried out for a panel of circulating pro-angiogenic and pro-inflammatory biomarkers: VEGF, placental growth factor (PlGF), soluble (s)VEGFR1/FLT-1, basic fibroblast growth factor (bFGF), VEGF-C, VEGF-D, sTIE-2, interleukin (IL)-1β, IL-2, IL-4, IL-6, IL-8, IL-10, IL-12p70, interferon (IFN)-α, and tumor necrosis factor (TNF)-α using Article Title: A Phase II and Biomarker Study of Sorafenib Combined with Modified FOLFOX in Patients with Advanced Hepatocellular Carcinoma Article Snippet: .. Plasma analysis was carried out for a panel of circulating pro-angiogenic and proinflammatory biomarkers: VEGF, placental growth factor (PlGF), soluble (s)VEGFR1/FLT-1, basic fibroblast growth factor (bFGF), VEGF-C, VEGF-D, sTIE-2, interleukin (IL)-1, IL-2, IL-4, IL-6, IL-8, IL-10, IL-12p70, interferon (IFN)-α, and tumor necrosis factor (TNF)-α using Article Title: PEARL: A Phase Ib/II Biomarker Study of Adding Radiation Therapy to Pembrolizumab Before Neoadjuvant Chemotherapy in Human Epidermal Growth Factor Receptor 2–Negative Breast Cancer Article Snippet: PURPOSE To assess safety and immune biomarkers after preoperative radiation therapy (RT) and anti-PD1 therapy in breast cancer.. MATERIALS AND METHODS Aphase I/IIb trial of pembrolizumabwithRTwas conducted inpatientswith triplenegative breast cancer (TNBC) and hormone receptor–positive/human epidermal growth factor receptor 2–negative (HR1/HER2–) breast cancer.. All received pembrolizumab followed by a second cycle 1 RT (anti-PD1/RT) of 24 Gy/three daily fractions delivered to the breast tumor and then neoadjuvant chemotherapy (NAC). Article Title: A Phase II and Biomarker Study of Cabozantinib in Patients with Advanced Cholangiocarcinoma Article Snippet: .. Plasma analysis was carried out for a panel of circulating pro-angiogenic and pro-inflammatory biomarkers: VEGF, placental growth factor (PlGF), soluble (s)VEGFR1/FLT-1, basic fibroblast growth factor (bFGF), VEGF-C, VEGF-D, TIE-2, interleukin (IL)-1β, IL-2, IL-4, IL-6, IL-8, IL-10, IL-12p70, interferon (IFN)-γ, and tumor necrosis factor (TNF)-α using Enzyme-linked Immunosorbent Assay:Article Title: A Phase II and Biomarker Study of Sorafenib Combined with Modified FOLFOX in Patients with Advanced Hepatocellular Carcinoma (HCC) Article Snippet: .. Plasma analysis was carried out for a panel of circulating pro-angiogenic and pro-inflammatory biomarkers: VEGF, placental growth factor (PlGF), soluble (s)VEGFR1/FLT-1, basic fibroblast growth factor (bFGF), VEGF-C, VEGF-D, sTIE-2, interleukin (IL)-1β, IL-2, IL-4, IL-6, IL-8, IL-10, IL-12p70, interferon (IFN)-α, and tumor necrosis factor (TNF)-α using Article Title: A Phase II and Biomarker Study of Sorafenib Combined with Modified FOLFOX in Patients with Advanced Hepatocellular Carcinoma Article Snippet: .. Plasma analysis was carried out for a panel of circulating pro-angiogenic and proinflammatory biomarkers: VEGF, placental growth factor (PlGF), soluble (s)VEGFR1/FLT-1, basic fibroblast growth factor (bFGF), VEGF-C, VEGF-D, sTIE-2, interleukin (IL)-1, IL-2, IL-4, IL-6, IL-8, IL-10, IL-12p70, interferon (IFN)-α, and tumor necrosis factor (TNF)-α using |